I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Boni, V.
474
results:
OpenAccess-fulltext X
Search for persons
X
Languages
english (436)
german (1)
more...
italian (1)
spanish (1)
portuguese (1)
french (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Lutein..:
Jhaveri, KL
;
Bellet, M
;
Turner, NC
...
730005. , 2024
Link:
https://repository.icr.a..
?
2
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet fo..:
Schmid, P
;
Turner, NC
;
Barrios, CH
...
731585. , 2024
Link:
https://repository.icr.a..
?
3
A phase I trial of LXS196, a protein kinase C (PKC) inhibit..:
Piperno-Neumann, S
;
Carlino, M. S
;
Boni, V
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006169/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
4
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in ..:
Oaknin, A
;
Pothuri, B
;
Gilbert, L
...
727516. , 2023
Link:
https://repository.icr.a..
?
5
Antitumor activity of lurbinectedin in combination with ora..:
Awada, A.H
;
Boni, V
;
Moreno, V
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808480/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
6
Lurbinectedin, a selective inhibitor of oncogenic transcrip..:
Boni, V
;
Pistilli, B
;
Braña, I
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.esmoop.2022.100571. , 2022
Link:
https://serval.unil.ch/n..
?
7
Lurbinectedin, a selective inhibitor of oncogenic transcrip..:
Boni, V
;
Pistilli, B
;
Braña, I
...
http://hdl.handle.net/10668/22220. , 2022
Link:
http://hdl.handle.net/10..
?
8
Efficacy and safety of larotrectinib in TRK fusion-positive..:
Doz, F
;
van Tilburg, CM
;
Geoerger, B
...
issn:1522-8517. , 2022
Link:
http://hdl.handle.net/11..
?
9
Lurbinectedin, a selective inhibitor of oncogenic transcrip..:
Boni, V
;
Pistilli, B
;
Braña, I
...
http://hdl.handle.net/10668/22220. , 2022
Link:
http://hdl.handle.net/10..
?
10
Lurbinectedin, a selective inhibitor of oncogenic transcrip..:
Boni, V
;
Pistilli, B
;
Braña, I
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588879/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
11
Effect of lurbinectedin on the QTc interval in patients wit..:
Fudio, S
;
Tabernero, J
;
Subbiah, V
...
http://zaguan.unizar.es/record/97222. , 2021
Link:
http://zaguan.unizar.es/..
?
12
RARE-07. EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC ..:
Perreault, S
;
Doz, F
;
Geoerger, B
...
issn:1522-8517. , 2021
Link:
http://hdl.handle.net/11..
?
13
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HR..:
Ho, AL
;
Brana, I
;
Haddad, R
...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, pp. JCO2002903 - ?. , 2021
Link:
https://repository.icr.a..
?
14
CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advance..:
Naing, A
;
Thistlethwaite, F
;
De Vries, EGE
...
https://discovery.ucl.ac.uk/id/eprint/10133504/1/e002447.full.pdf. , 2021
Link:
https://discovery.ucl.ac..
?
15
Efficacy and safety of larotrectinib in TRK fusion-positive..:
Doz, F
;
van Tilburg, CM
;
Geoerger, B
...
Neuro-Oncology. , 2021
Link:
https://repository.icr.a..
1-15